| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Prelude Therapeutics Incorporated (PRLD) has 6 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. PRLD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 11.81M | $50.54M | - | |
| 10% | 6.48M | $27.72M | - | |
| 10% | 1.13M | $4.82M | - | |
| Dir | 121.3K | $519.1K | - | |
| Pres | 86.9K | $372.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2020 | Morosini Deborah82 | EVP, Chief Of Clinical Affairs | Buy | 444 | $19.00 | $8,436.00 | New | |
| Sep 29, 2020 | Pierce Christopher82 | EVP And Chief Of Business Oper | Buy | 3,750 | $19.00 | $71,250.00 | New | |
| Sep 29, 2020 | Dier Mardi70 | Director | Buy | 10,000 | $19.00 | $190,000.00 | New | |
| Sep 29, 2020 | Combs Andrew56 | EVP, Head Of Chemistry | Buy | 1,000 | $19.00 | $19,000.00 | +0.4% | |
| Sep 29, 2020 | Baker Bros. Advisors LP59 | Director, 10% Owner | Buy | 1,578,947 | $19.00 | $29,999,993.00 | +18.5% | |
| Sep 25, 2020 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 1,236,800 | $19.00 | $23,499,200.00 | +597.7% | |
| Sep 25, 2020 | Bonita David P66 | Director, 10% Owner | Buy | 1,236,800 | $19.00 | $23,499,200.00 | +597.7% |